With passion for patients and science, we are developing therapies for indications in the field of viral infectious diseases and autoreactive immune disorders.
Marinomed has the vision to transform the lives of people suffering from diseases with limited or no treatment options in two key therapeutic areas: virology and immunology. Driven by curiosity, patented technologies, and a deep understanding of the underlying science, we uncover unconventional paths no one has gone before.
Marinomed develops medicinal products and medical devices to help patients combat viral infectious diseases and autoreactive immune disorders.
Marinomed is listed on the prime market segment of the Vienna stock exchange since February 2019.
Marinomed Biotech AG, listed on the Vienna Stock Exchange (VSE:MARI), today announced positive results from its clinical…
Marinomed Biotech AG, listed on the Vienna Stock Exchange (VSE:MARI), achieved important progress in strategic growth…